Case report: Treatment of left-sided valve endocarditis using the Transapical AngioVac System and cerebral embolism protection device: A case series

Case report: Treatment of left-sided valve endocarditis using the Transapical AngioVac System and cerebral embolism protection device: A case series

The AngioVac System (AngioDynamics, Latham, NY) was developed for the treatment of right-sided heart and intravenous masses. Lately, it has been employed to deal with left-sided heart masses, in particular, native valve endocarditis (NVE) and valve prostheses endocarditis (VPE) in high-risk patients...

Full description

Bibliographic Details
Main Authors: Alessandro Fiocco, Andrea Colli, Laura Besola
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
valve endocarditis
AngioVac System
TriGuard embolic protection device
minimally invasive
transapical access
prosthesis endocarditis
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1121488/full

Similar Items

Similar Items